Browse
Submit Data
Databases
API
Help

Dataset Information

8 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Low power threshold photochemical upconversion using a zirconium(iv) LMCT photosensitizer.

ABSTRACT: The current investigation demonstrates highly efficient photochemical upconversion (UC) where a long-lived Zr(iv) ligand-to-metal charge transfer (LMCT) complex serves as a triplet photosensitizer in concert with well-established 9,10-diphenylanthracene (DPA) along with newly conceived DPA-carbazole based acceptors/annihilators in THF solutions. The initial dynamic triplet-triplet energy transfer (TTET) processes (ΔG ∼ -0.19 eV) featured very large Stern-Volmer quenching constants (K _SV) approaching or achieving 10⁵ M^-1 with bimolecular rate constants between 2 and 3 × 10⁸ M^-1 s^-1 as ascertained using static and transient spectroscopic techniques. Both the TTET and subsequent triplet-triplet annihilation (TTA) processes were verified and throughly investigated using transient absorption spectroscopy. The Stern-Volmer metrics support 95% quenching of the Zr(iv) photosensitizer using modest concentrations (0.25 mM) of the various acceptor/annihilators, where no aggregation took place between any of the chromophores in THF. Each of the upconverting formulations operated with continuous-wave linear incident power dependence (λ _ex = 514.5 nm) down to ultralow excitation power densities under optimized experimental conditions. Impressive record-setting η _UC values ranging from 31.7% to 42.7% were achieved under excitation conditions (13 mW cm^-2) below that of solar flux integrated across the Zr(iv) photosensitizer's absorption band (26.7 mW cm^-2). This study illustrates the importance of supporting the continued development and discovery of molecular-based triplet photosensitizers based on earth-abundant metals.

SUBMITTER: Yang M

PROVIDER: S-EPMC8261719 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Low threshold lasing emissions from a single upconversion nanocrystal.

Project description:Cross-relaxation among neighboring emitters normally causes self-quenching and limits the brightness of luminescence. However, in nanomaterials, cross-relaxation could be well-controlled and employed for increasing the luminescence efficiency at specific wavelengths. Here we report that cross-relaxation can modulate both the brightness of single upconversion nanoparticles and the threshold to reach population inversion, and both are critical factors in producing the ultra-low threshold lasing emissions in a micro cavity laser. By homogenously coating a 5-μm cavity with a single layer of nanoparticles, we demonstrate that doping Tm3+ ions at 2% can facilitate the electron accumulation at the intermediate state of 3H4 level and efficiently decrease the lasing threshold by more than one order of magnitude. As a result, we demonstrate up-converted lasing emissions with an ultralow threshold of continuous-wave excitation of ~150 W/cm2 achieved at room temperature. A single nanoparticle can lase with a full width at half-maximum as narrow as ~0.45 nm.

| S-EPMC7708641 | biostudies-literature

Rapid and durable photochemical bonding of cartilage using the porphyrin photosensitizer verteporfin.

Project description:ObjectiveTo evaluate the effectiveness of verteporfin as a photosensitizer to photochemically bond articular cartilage tissues and determine bond durability in vitro.DesignBond strength induced by verteporfin over a range of concentrations and light exposure conditions was investigated using a disk-annulus model and a pushout test. Exposure was parameterized by varying either irradiance or irradiation time. Bond robustness in a cell-mediated degeneration environment was examined by exposing newly bonded samples to interleukin-1 alpha for the first 4 days of a 7-day culture period, followed by mechanical testing and biochemical and cellular viability assays.ResultsPhotochemical bonding using verteporfin produced high bonding shear strengths at relatively low photosensitizer concentrations. Low exposures produced by either low irradiance or short irradiation time were sufficient to produce shear strengths comparable to those previously produced with phthalocyanine photosensitizers with substantially higher light exposure. Photochemically produced bonds were resistant to cell-mediated degeneration in vitro with no evident differences in cell viability among treatments.ConclusionsVerteporfin offers distinct advantages as a photosensitizer for photochemical bonding of articular cartilage due to the production of strong, durable bonds at relatively low light exposures. Further exploration may lead to clinically feasible strategies to augment cartilage repair techniques.

| S-EPMC7409723 | biostudies-literature

Zirconium(IV) dilanthanum(III) penta-sulfide.

Project description:Zirconium(IV) dilanthanum(III) penta-sulfide, ZrLa(2)S(5), crystallizes with four formula units in the space group Pnma in the U(3)S(5) structure type. The asymmetric unit comprises one Zr, one La and four S atoms. The Zr and three S atoms are situated on mirror planes. The structure consists of LaS(8) face-sharing bicapped distorted trigonal prisms and ZrS(7) edge-sharing monocapped octa-hedra.

| S-EPMC3238577 | biostudies-literature

Direct oligonucleotide-photosensitizer conjugates for photochemical delivery of antisense oligonucleotides.

Project description:Activation of photosensitizers in endosomes enables release of therapeutic macromolecules into the cytosol of the target cells for pharmacological actions. In this study, we demonstrate that direct conjugation of photosensitizers to oligonucleotides (ONs) allows spatial and temporal co-localization of the two modalities in the target cells, and thus leads to superior functional delivery of ONs. Further, light-activated delivery of an anticancer ON caused cancer cell killing via modulation of an oncogene and photodynamic therapy.

| S-EPMC4405145 | biostudies-literature

Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapy.

Project description:Photodynamic therapy (PDT) is a promising treatment modality for cancer and other malignant diseases, however safety and efficacy improvements are required before it reaches its full potential and wider clinical use. Herein, we investigated a highly efficient and safe photodynamic therapy procedure by developing a high/low power density photodynamic therapy mode (high/low PDT mode) using methoxypoly(ethylene glycol) thiol (mPEG-SH) modified gold nanorod (GNR)-AlPcS4 photosensitizer complexes. mPEG-SH conjugated to the surface of simple polyelectrolyte-coated GNRs was verified using Fourier transform infrared spectroscopy; this improved stability, reduced cytotoxicity, and increased the encapsulation and loading efficiency of the nanoparticle dispersions. The GNR-photosensitizer complexes were exposed to the high/low PDT mode (high light dose = 80 mW/cm(2) for 0.5 min; low light dose = 25 mW/cm(2) for 1.5 min), and a high PDT efficacy leads to approximately 90% tumor cell killing. Due to synergistic plasmonic photothermal properties of the complexes, the high/low PDT mode demonstrated improved efficacy over using single wavelength continuous laser irradiation. Additionally, no significant loss in viability was observed in cells exposed to free AlPcS4 photosensitizer under the same irradiation conditions. Consequently, free AlPcS4 released from GNRs prior to cellular entry did not contribute to cytotoxicity of normal cells or impose limitations on the use of the high power density laser. This high/low PDT mode may effectively lead to a safer and more efficient photodynamic therapy for superficial tumors.

| S-EPMC4577028 | biostudies-literature

Zirconium(IV)-IMAC for phosphopeptide enrichment in phosphoproteomics

Project description:IMAC and MOAC magnetic microsphere materials were tested with ug amounts of protein extracts from HepG2/C3A cells. We compared Zirconium (IV) IMAC (Zr-IMAC) magnetic microspheres to commonly used Titanium (IV) IMAC (Ti-IMAC) and TiO2 magnetic microspheres for phosphopeptide enrichment from simple and complex protein samples prior phosphopeptide sequencing and characterization by mass spectrometry (LC-MS/MS). We optimized sample-loading conditions to increase phosphopeptide recovery for Zr-IMAC, Ti-IMAC and TiO2 based workflows. Furthermore, optimized Zr-IMAC and Ti-IMAC magnetic microsphere format were compared to HPLC-based Fe(III)-IMAC for same sample amount (200 ug).

2020-11-26 | PXD018273 | Pride

Transparent organic upconversion devices displaying high-resolution, single-pixel, low-power infrared images perceived by human vision.

Project description:Crystalline photodiodes remain the most viable infrared sensing technology of choice, yet the opacity and the limitation in pixel size reduction per se restrict their development for supporting high-resolution in situ infrared images. In this work, we propose an all-organic non-fullerene-based upconversion device that brings invisible infrared signal into human vision via exciplex cohost light-emissive system. The device reaches an infrared-to-visible upconversion efficiency of 12.56% by resolving the 940-nm infrared signal (power density of 103.8 μW cm-2). We tailor a semitransparent (AVT, ~60%), large-area (10.35 cm2), lightweight (22.91 g), single-pixel upconversion panel to visualize the infrared power density down to 0.75 μW cm2, inferring a bias-switching linear dynamic range approaching 80 dB. We also demonstrate the possibility of visualizing low-intensity infrared signals from the Face ID and LiDAR, which should fill the gap in the existing technology based on pixelated complementary metal-oxide semiconductors with optical lenses.

| S-EPMC10132748 | biostudies-literature

A Photochemical Avenue to Photoluminescent N-Dots and their Upconversion Cell Imaging.

Project description:A photochemical avenue to synthesize nitrogen-rich quantum dots (N-dots) using 2-azido imidazole as the starting material was established for the first time. A production yield of up to 92.7% was obtained. The N-dots were then fully characterized by elemental analysis, IR, XPS, XRD, AFM and TEM. On the basis of the N2 production and in situ IR results, the underlying mechanism for the photochemical formation of N-dots was proposed. These N-dots showed promising optical properties including wavelength-dependent upconversion photoluminescence, and were successfully used in upconversion cell imaging.

| S-EPMC5431983 | biostudies-literature

Terminal Parent Phosphanide and Phosphinidene Complexes of Zirconium(IV).

Project description:The reaction of [Zr(TrenDMBS )(Cl)] [Zr1; TrenDMBS =N(CH2 CH2 NSiMe2 But )3 ] with NaPH2 gave the terminal parent phosphanide complex [Zr(TrenDMBS )(PH2 )] [Zr2; Zr-P=2.690(2)?Å]. Treatment of Zr2 with one equivalent of KCH2 C6 H5 and two equivalents of benzo-15-crown-5 ether (B15C5) afforded an unprecedented example (outside of matrix isolation) of a structurally authenticated transition-metal terminal parent phosphinidene complex [Zr(TrenDMBS )(PH)][K(B15C5)2 ] [Zr3; Zr=P=2.472(2)?Å]. DFT calculations reveal a polarized-covalent Zr=P double bond, with a Mayer bond order of 1.48, and together with IR spectroscopic data also suggest an agostic-type Zr???HP interaction [?ZrPH =66.7°] which is unexpectedly similar to that found in cryogenic, spectroscopically observed phosphinidene species. Surprisingly, computational data suggest that the Zr=P linkage is similarly polarized, and thus as covalent, as essentially isostructural U=P and Th=P analogues.

| S-EPMC5575506 | biostudies-literature

Achieving efficient photodynamic therapy under both normoxia and hypoxia using cyclometalated Ru(ii) photosensitizer through type I photochemical process.

Project description:Photodynamic therapy (PDT) through the generation of singlet oxygen utilizing photosensitizers (PSs) is significantly limited under hypoxic conditions in solid tumors. So it is meaningful to develop effective PSs which can maintain excellent therapeutic effects under hypoxia. Here we reported a coumarin-modified cyclometalated Ru(ii) photosensitizer (Ru2), which exhibits lower oxidation potential and stronger absorption in the visible region than the coumarin-free counterpart. The evaluation of the PDT effect was performed under both normoxia and hypoxia. The results showed that Ru2 has a better therapeutic effect than the coumarin-free counterpart in in vitro experiments. Especially under hypoxia, Ru2 still retained an excellent PDT effect, which can be attributed to the direct charge transfer between the excited PS and an adjacent substrate through a type I photochemical process, forming highly-oxidative hydroxyl radicals to damage tumor cells. The anti-tumor activity of Ru2 was further proven to be effective in tumor-bearing mice, and tumor growth was inhibited remarkably under PDT treatment.

| S-EPMC5868078 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data